"Bulletin","Class_of_antibiotics","Antibiotic","Isolated","Resistance","95_IC_low","95_IC_upper"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Penicilline","Piperacillina-Tazobactam",2938,"23.9","22.4","25.5"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Cefalosporine III generazione","Ceftazidime",2974,"19.9","18.5","21.4"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Cefalosporine III generazione","Cefepime",2617,"18.8","17.3","20.3"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Carbapenemi","Imipenem",2329,"16.7","15.2","18.2"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Carbapenemi","Meropenem",2988,"11.2","10.1","12.4"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Aminoglicosidi","Amikacina",2908,"5.5","4.7","6.4"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Aminoglicosidi","Gentamicina",2983,"12.8","11.7","14.1"
